(Q73415875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

T Matos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Cufer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Cervek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Bornstnar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B Kragelj

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Zumer-Pregelj

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

403-409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

Selective bladder preservation by combination treatment of invasive bladder cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Invasive bladder cancer: our experience with bladder sparing approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Organ-sparing treatment for bladder cancer: time to beat the drum

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

The prognostic significance of ureteral obstruction in carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Clinical prognostic factors in transitional cell cancer of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Deoxyribonucleic Acid Flow Cytometry in Invasive Bladder Carcinoma: A Possible Predictor for Successful Bladder Preservation following Transurethral Surgery and Chemotherapy-Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Age as a prognostic factor in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Combination of 5-fluorouracil, imidazole carboxamide, BCNU and prednisolone (FIB-P) as a salvage chemotherapy in heavily pretreated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900385-5

7 January 2021

10.1016/S0360-3016(99)00385-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10661347%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference